The Company is an award-winning, leading supplier ofbranded fresh-frozen shrimp to major import markets in Asia, Europe and the U.S. The Company’s 20-year genetics program has led to remarkable advances in growth rate, survival and disease resistance, while maintaining an impressive 75% genetic diversity from its original shrimp stock.
Using high-tech selective breeding methods to produce an outstanding pedigree, the Company’s biologists and genetics experts have improved reproduction, production and yields to create shrimp that are healthier, stronger and more resilient than other varieties. There are three related operations included in this offering comprised of hatchery, farm land and processing plant, including also their headquarters. Approximately 83% of sales are shrimp and 17% are larvae. The Company has a proprietary portfolio of genetic and technological assets and its brand name is recognized for superior quality, freshness and taste.
A highly-scalable and integrated operation, the Company is positioned to ramp up capacity as it continues to focus on optimizing production practices, forging technological breakthroughs and maintaining quality yields. Complying with the highest international standards in environmental, health, security and quality, the Company operates a state-of-the-art hatchery, three farms and an onsite processing plant located in a tax-free trade zone. All management and staff are dedicated to the Company’s continued prosperity and are expected to remain in place under new ownership. Management expects to make substantial improvements in EBITDA margins in 2016 due to new efficiencies achieved in its food conversion feed ratio. Projected revenue growth of about 24% is expected in 2017 due to a third harvest planned in addition to the normal two harvests per year.